Preclinical services for biopharmaceutical product development

Award Notice Posted

Solicitation number
75N93022R00004
Agency
Awarded
to Research Triangle Institute
Set-aside
No set-aside

Opportunity facts

Contract number
75N93023D00012 Federal IDV award
Place of performance
Durham, North Carolina 27709, United States

Notice details come from SAM.gov. Updated .

About this opportunity

This Award Notice from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a contract to Research Triangle Institute for preclinical services for biopharmaceutical product development. The contract is an indefinite-delivery/indefinite-quantity agreement with a minimum value of $2,000 and maximum value of $30,000,000 to provide services under Task Area E - Regulatory Activities and Documentation. The initial award amount is $30,000,000.

Notice text

Base IDIQ Award
Minimum $2,000
Maximum $30,000,000

Task Area Awarded
Task Area E - Regulatory Activities and Documentation

Awarded contract 75N93023D00012 to Research Triangle Institute for 30000000.00 on 2023-09-08.

Notice history

Notice Type Posted
Preclinical services for biopharmaceutical product development Latest Award Notice
Preclinical services for biopharmaceutical product development Award Notice
This notice Award Notice
Preclinical services for biopharmaceutical product development Award Notice
Preclinical services for biopharmaceutical product development Latest solicitation Solicitation
Preclinical services for biopharmaceutical product development Pre-Solicitation
Preclinical services for biopharmaceutical product development Original Pre-Solicitation

7 of 10 notices listed here. See the rest on GovTribe.

Similar open opportunities

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity